Business Context and Reporting Period
This Form 8-K was filed by Integrity Applications, Inc. (not Glucotrack, Inc., which is the name of the company's product) on October 25, 2021. The report details a significant executive appointment and a change in board composition effective November 1, 2021.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It is a current report focused on corporate governance and personnel changes rather than financial performance.
Material Changes
- Executive Appointment: Paul V. Goode was appointed as President and Chief Operating Officer (COO), effective November 1, 2021.
- Board Change: Concurrent with his new role, Mr. Goode is stepping down from the Board of Directors, where he had served since December 17, 2020.
- Strategic Focus: Mr. Goode will lead operations, strategy, design, manufacturing, and product development, with a specific mandate to build U.S. infrastructure in preparation for U.S. clinical trials of the GlucoTrack device.
Compensation and Employment Terms
The employment agreement outlines the following compensation structure for Mr. Goode:
- Base Salary: $175,000 per year.
- Cash Bonus: Up to 20% of the annual base salary, determined by the Compensation Committee.
- Equity Grant: Options to purchase up to 1.5% of the fully diluted common stock.
- Exercise Price: The greater of $5.20 per share or the closing price on the Effective Date.
- Vesting: Equal monthly installments over a three-year period.
- Clawback Provisions: Bonus and equity incentives are subject to clawback in the event of financial misstatements affecting underlying metrics.
Investor Verification Checklist
- Verify the exact closing price of Integrity Applications, Inc. stock on November 1, 2021, to determine the final exercise price of the equity grant.
- Confirm the current status of the U.S. clinical trials for the GlucoTrack device, as this is the primary strategic objective assigned to the new COO.
- Review the company's cash position to assess its ability to fund the new U.S. infrastructure and the executive compensation package.
- Check for any subsequent filings regarding the vesting schedule or performance metrics tied to the cash bonus.